SGLT-2i also mitigates oxidative stress and inflammation by modulating NADPH oxidases and protein kinase C, reducing reactive oxygen species and systemic inflammation, which benefits vascular stability and lowers infection risks in patients with T2DM [49,50,51]. This evidence concerns the gene FMO5 and type 2 diabetes mellitus.